Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Safety,Usability and Compliance of Using C-Scan System for Providing Information on Colonic Polypoid Lesions and Masses [NA]
Clinical trial update on safety, usability, and compliance of the C-Scan system for identifying colonic polypoid lesions and masses in color…
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial update evaluating fruquintinib combined with chemotherapy as second-line treatment for metastatic colorectal cancer, …
-
CLINICAL_TRIALS trial_result · 2023-08-29Clinical Trial Update: Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of VE800 in combination with nivolumab has completed enrollment and posted results for selected advanced cancers. T…
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRC [Phase 2]
A Phase 2 clinical trial exploring Fruquintinib combined with mFOLFOX6/FOLFIRI as first-line therapy to enable conversion surgery in metasta…
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: PCA Ketamine-Morphine VS PCA Morphine as Post-Operative Analgesia in Colorectal Surgery. [Phase 4]
Phase 4 trial comparing patient-controlled analgesia with ketamine-morphine versus morphine alone for postoperative analgesia in colorectal …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Intraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab [Phase 2]
A Phase 2 clinical trial evaluating intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for colorectal cancer with peritoneal…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line Treatment [Phase 2]
Phase 2 trial evaluating HLX208 (BRAF V600E inhibitor) in combination with cetuximab for metastatic colorectal cancer with BRAF V600E mutati…
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Chemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate [Phase 2]
Phase 2 trial evaluating chemotherapy plus immunotherapy for microsatellite-stable metastatic colorectal cancer with high immune infiltrate.
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial evaluating selective internal radiation therapy with Xelox, bevacizumab, and atezolizumab in patients with liver-domi…
-
CLINICAL_TRIALS trial_result · 2023-08-16Clinical Trial Update: Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery [Phase 3]
Phase 3 trial investigating rosuvastatin in patients with surgically removed stage I/II colorectal cancer; study terminated with posted resu…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: U01 CRC Project for Vietnamese Americans [NA]
Clinical trial update for the U01 CRC Project focusing on Vietnamese Americans with colorectal cancer; study status completed and results po…
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: The Efficacy and Safety of HLX208 in Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation [Phase 2]
Phase 2 clinical trial update assessing HLX208 for efficacy and safety in metastatic colorectal cancer with BRAF V600E mutation.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer [Phase 3]
Phase 3 trial comparing cetuximab plus best supportive care versus best supportive care alone in metastatic EGFR-positive colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer [Phase 3]
Phase 3 trial evaluating cetuximab with or without brivanib in patients with K-Ras wild type metastatic colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer. [Phase 1, Phase 2]
Clinical trial update for a combination of a PI3K inhibitor BKM120 with panitumumab in metastatic/advanced RAS-wild type colorectal cancer (…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal Cancer [Phase 3]
Phase 3 trial evaluating cetuximab plus capecitabine as maintenance therapy in metastatic colorectal cancer with wild-type RAS/BRAF; status …
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep [Phase 4]
Phase 4 trial comparing Miralax with Gatorade versus Movi Prep for colorectal cancer patients, reporting efficacy and patient satisfaction.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Fruquintinib Plus FOLFIRI in RAS-mutated Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial update evaluating Fruquintinib plus FOLFIRI in RAS-mutated metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer [Phase 3]
Phase 3 trial evaluating chemotherapy in combination with autologous cell immunotherapy for recurrent and metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer [Phase 2]
Phase 2 trial of amifostine (Ethyol) in colorectal cancer was terminated; results posted in 2023.
-
CLINICAL_TRIALS research · 2023-08-01Clinical Trial Update: Paired Promotion of Colorectal Cancer and Social Determinants of Health Screening [NA]
Clinical trial update documenting paired promotion of colorectal cancer awareness with screening for social determinants of health; study st…
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients [Phase 2]
A Phase 2 clinical trial evaluating the effect of losartan on the incidence and severity of chemotherapy-induced mucositis in gastrointestin…
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM [Phase 3]
A Phase 3 trial comparing cetuximab plus mFOLFOX6 versus mFOLFOX6 alone in patients with RAS/BRAF wild-type, high-risk resectable colorectal…
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC [Phase 2]
A Phase 2 clinical trial updating surufatinib, toripalimab, and chemotherapy in second-line metastatic and microsatellite-stable colorectal …